WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ('WIMI' or the 'Company'), a leading global Hologram Augmented Reality ('AR') Technology provider, has completed systematic benchmark testing on fully ...
Artificial Intelligence (AI) demonstrates significant potential to enhance diagnostic precision, personalised treatment, and ...
Operational autonomy is quickly becoming one of the defining capabilities of a modern enterprise. As digital estates become ...
MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the “Company”), a technology service provider, has announced a groundbreaking achievement of great theoretical and engineering significance: its ...
Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...
Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the ...
Advances in recent years suggest we are entering the Quantum Frontier Era. National security, science, economic ...
Morning Overview on MSN
The FDA cleared the first blood test to help diagnose Alzheimer’s in a doctor’s office
Adults showing signs of memory loss and cognitive decline can now be screened for Alzheimer’s disease with a simple blood ...
India’s 2026 AI court regulations ban predictive risk scoring and algorithmic justice. Can judicial oversight keep pace with court automation?
Post-quantum cryptography military deadline: the Department of War’s first PQC strategy sets a binding 2031 mandate for every ...
Remote analytics teams handle some of the most valuable assets in modern organizations: customer information, operational ...
Artificial intelligence (AI) is increasingly reshaping diagnostic pathology, with breast pathology representing one of the most advanced and clinically impactful areas of adoption.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results